Our mission: Save lives through improved patient care.
At NeoGenomics, everything we do is to better patient care. We are dedicated to increasing and improving access to care and advancing patient outcomes through transformative oncology testing. As a leader in cancer diagnostics, NeoGenomics has more than 15 years of experience diagnosing and analyzing various forms of solid tumors and blood cancers. Our organization is an integral part of the cancer care team by providing vital insights about a cancer’s diagnosis, prognosis, and therapy assignment. We work with oncology providers to give insights into your cancer’s thumbprint and help guide personalized treatment decisions to help optimize care, also known as precision medicine.
NeoGenomics takes cancer personally; every person is unique and we believe in walking hand-in-hand with you and your care team during your personal cancer journey.
“My liquid biopsy test has potentially bought me several more years that I wouldn’t have had otherwise. That’s something that money can’t buy.”
Sasha was a warrior and fought to make the world around her a better place, Sasha lost her battle with Lung Cancer in 2021. At NeoGenomics, we are extremely grateful to Sasha and her family for sharing the journey with us as we continue to focus on improving outcomes for patients daily.
NeoGenomics is committed to working with patients and their insurance companies to ensure every patient has access to high-quality cancer testing.
In-home Blood Draws
NeoGenomics provides safe and convenient access to liquid biopsy testing through our national mobile phlebotomy program. This service is offered at no cost to patients.
Sponsored Testing Programs
NeoGenomics works with its partners to create pathways to emerging advances in personalized medicine. These programs offer reduced or no-cost tests to patients.
We’re Here to Help
Looking for additional information on NeoGenomics testing capabilities? Our Patient Services team is on hand to help.